Eye drop gives hope for knifeless cataract cure

July 22, 2015
eye

An eye drop tested on dogs suggests that cataracts, the most common cause of blindness in humans, could one day be cured without surgery, a study said Wednesday.

A naturally-occurring molecule called lanosterol, administered with an eye dropper, shrank canine , a team of scientists reported in Nature.

Currently the only treatment available for the debilitating growths, which affect tens of millions of people worldwide, is going under the knife.

While surgery is generally simple and safe, the number of people who need it is set to double in the next 20 years as populations age. And for many, it remains prohibitively costly.

The chain of research leading to the potential cure began with two children—patients of lead researcher Kang Zhang of Sun Yat-sen University in Guangzhou—from families beset with a congenital, or inherited, form of the condition.

Zhang and colleagues discovered that his patients shared a mutation in a gene critical for producing lanosterol, which the researchers suspected might impede cataract-forming proteins from clumping in normal eyes.

In a first set of lab experiments on cells, they confirmed their hunch that lanosterol helped ward off the proteins.

In subsequent tests, dogs with naturally-occurring cataracts received drops containing the molecule.

After six weeks of treatment, the size and characteristic cloudiness of the cataracts had decreased, the researchers reported.

"Our study identifies lanosterol as a key molecule in the prevention of lens protein aggregation and points to a novel strategy for cataract prevention and treatment," the authors concluded.

Cataracts account for half of blindness cases worldwide.

"These are very preliminary findings," said J. Fielding Hejtmancik, a scientist at the US National Eye Institute, who wrote a commentary also published in Nature.

"Before there are any human trials, the scientists will probably test other molecules to see if they might work even better," he told AFP by telephone.

The preliminary results, he added, "doesn't mean that lanosterol is the only or the best compound" to reduce cataracts. mh/mlr/pvh

Explore further: New DNA test for diagnosing diseases linked to childhood blindness

More information: Nature DOI: 10.1038/nature14650

Related Stories

Scientists identify mutations that cause congenital cataracts

June 2, 2011

New research identifies genetic mutations that cause an inherited form of cataracts in humans. The study, published online June 2 by Cell Press in the American Journal of Genetics, provides new insight into the understanding ...

Recommended for you

Reproducing a retinal disease on a chip

June 15, 2017

Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017

In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

baudrunner
not rated yet Jul 22, 2015
I like this. I have had the cataract surgeries on both eyes, and my vision has improved substantially. I highly recommend it. What science has yet to accomplish is to provide a solution for floaters. I have had my share of hard knocks, and the floaters are an annoyance, aggravated by the fact that nothing can be done about them. Maybe this product, or something similar, can remove them.
omatwankr
not rated yet Jul 22, 2015
"the floaters are an annoyance, aggravated by the fact that nothing can be done about them"

http://www.dailym...ion.html

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.